Table 1.
Expression of LCP1 and miR-135a-5p According to Patients’ Clinical Features
| Characteristics | Number | LCP1 Expression |
p Value | miR-135a-5p Expression |
p Value | ||
|---|---|---|---|---|---|---|---|
| High Group | Low Group | High Group | Low Group | ||||
| Age (Years) | |||||||
| <18 | 25 | 10 | 15 | 0.41 | 11 | 14 | 0.80 |
| ≥18 | 15 | 8 | 7 | 6 | 9 | ||
| Gender | |||||||
| Female | 22 | 12 | 10 | 0.95 | 9 | 13 | 0.57 |
| Male | 18 | 10 | 8 | 9 | 9 | ||
| Location | |||||||
| Femur/tibia | 33 | 16 | 17 | 0.79 | 14 | 19 | 0.48 |
| Elsewhere | 7 | 3 | 4 | 4 | 3 | ||
| TNM Stage | |||||||
| I | 19 | 8 | 11 | 0.028a | 13 | 6 | 0.027a |
| II/III | 21 | 16 | 5 | 7 | 14 | ||
| Tumor Size (cm) | |||||||
| <5 | 18 | 7 | 11 | 0.031a | 12 | 6 | 0.028a |
| ≥5 | 22 | 16 | 6 | 7 | 15 | ||
| Metastasis | |||||||
| Yes | 16 | 12 | 4 | 0.02a | 5 | 11 | 0.028a |
| No | 24 | 9 | 15 | 16 | 8 | ||
Expression levels of LCP1 and miR-135a-5p were correlated with tumor TNM stage and metastasis, according to the clinical features of 40 patients.
p < 0.05 (chi-square test).